Loading…
Ziff Davis, Inc.
🏹 Trader: 🚀 Stage 2 + Near High 📈 Stage 2 🎯 Near 52W High | BRS 85 Ready View all →
📈 Stage 2 detected Find the fundamental catalyst → → run Growth Triggers in Ask AI
$2.3B
Market Cap
30.6
P/E
0.69
PEG
6.1%
ROCE
2.7%
ROE
0.51
D/E
13.6%
OPM
-0.8%
% from 52W High
85
α RS
🔍 ZD is showing a sector-leadership setup because Sector RRG has Communication Services in the Leading quadrant with the trail still strengthening, it matches 2 of 39 tracked screener presets, and RS Rating is 85. Net: Broad signal stack, not a recommendation. ? RRG Conviction RS Rating
Sources
Communication Services in Leading quadrant · Conviction 2/39 · RS Rating 85
⚖️ Compare 🔒 Generate Report 🔒 Research Packet 📚 Guides
🌏 Global Investor Returns
Currency-adjusted total returns for ZD including FX impact
🌏
Click 🌏 Returns tab to load data
📈 Price History
Ratio Health
Excellent
Good
Average
Poor
By Category
📊 Sector Averages
About

Ziff Davis, Inc., together with its subsidiaries, operates as a digital media and internet company in the United States and internationally. It offers online resources for laboratory-based product reviews, technology news, buying guides, and research papers under the PCMag and CNET brands; Mashable for publishing technology and culture content; Spiceworks provides digital content of IT products and services; RetailMeNot, a savings destination platform; VoucherCodes; Offers.com, a coupon and deals website; and event based properties, includes BlackFriday.com, TheBlackFriday.com, BestBlackFriday.com, and DealsofAmerica.com. It also offers gaming and entertainment platforms under the IGN Entertainment and Humble Bundle brands; and information on internet connectivity under the Speedtest, Ookla, Ekahau, Downdetector, and RootMetrics brands. The company also offers digital content and information services for health and wellness consumers under the Everyday Health, DailyOM, Lose It!, Castle Connolly, and Migraine Again brands; pregnancy and parenting content under the BabyCenter, Mom 2.0, Emma’s Diary, Medpage Today, and What to Expect brands. In addition, it offers PRIME Education, a medical education program for healthcare professionals; and Health eCareers, a digital portal for healthcare professionals. Further, it provides endpoint and email security, security awareness training, secure backup and file sharing, and virtual private network solutions under the IPVanish, VIPRE, Livedrive, Inspired eLearning, and SugarSync brands; and email marketing and delivery solutions, search engine optimization tools, and voice and text communication services under the Campaigner, iContact, SMTP, Kickbox, Full Contact, MOZ Pro, MOZ Local, Stat Analytics, eVoice, and Line2 brands. The company was formerly known as j2 Global, Inc. and changed its name to Ziff Davis, Inc. in October 2021. The company was incorporated in 2014 and is headquartered in New York, New York.

Key Ratios Snapshot
📈 Growth Pattern
📊 Quick Scorecard
Loading…
🔒
Premium Feature
AI-generated 10-section company profile — business model, financials, strengths, risks & management quality
Upgrade to Premium
Already a member? Log in
📐
3-Statement Financial Model
Bear / Base / Bull projections · DCF fair value · Reverse-DCF
Open Model →
🎙 Management Tone Confident Specific ~ Volatile 4 quarters Full tone analysis in Intelligence →
📊 MIXED Ziff Davis Q1 2026: Revenue $267.6M, adjusted EBITDA $63.4M, asset monetization pivot
Revenue & Profitability
Q1 2026 revenue from continuing operations was $267.6 million, down 1.9% year-over-year. Adjusted EBITDA was $63.4 million, compared to $71.4 million in Q1 2025, with a margin of 23.7% (down 2.5 percentage points). Adjusted diluted EPS was $0.73 versus $0.77 in the prior year. Free cash flow for the quarter was negative $3.2 million, but the trailing twelve months free cash flow was nearly $290 million. The company had $520 million in cash and cash equivalents and $100 million in long-term investments.
Outlook
Management expects Q2 2026 revenues from continuing operations to be down at a slightly higher year-over-year rate than Q1, with a similar decline in adjusted EBITDA margins. The goal is to return to total year-over-year revenue growth in the second half of 2026, with Q4 stronger than Q3. Margins are expected to improve in H2, approaching H2 2025 levels. The company faces ongoing traffic headwinds in tech and shopping but sees sequential improvement each quarter.
Growth Drivers
Key growth drivers include off-platform monetization, with social video views growing over 75% year-over-year across Instagram, YouTube, and TikTok. Gaming and entertainment revenue grew over 7%, driven by a record quarter at Humble Bundle. Health and wellness saw strong consumer pharma ad revenues from GLP-1 ads and momentum in the hospital media network. Cybersecurity and MarTech revenue grew nearly 4%, with new product releases like IPVanish Threat Protection Pro.
Balance Sheet & CapEx
Not discussed in this earnings call.
Margins
Q1 2026 adjusted EBITDA margin was 23.7%, down 2.5 percentage points year-over-year due to lower high-margin affiliate traffic and revenue mix shifts. Tech and shopping, gaming, health, and cybersecurity margins all declined year-over-year. Q2 is expected to see a similar margin decline, but H2 margins should improve, approaching H2 2025 levels. The sale of the higher-margin connectivity business will pressure margins, but the company plans to offset this through AI and operational efficiency.
Key Risks
Risks include continued traffic pressures in tech and shopping affecting affiliate commerce and programmatic display advertising. MedPage Today experienced booking delays from key pharma clients, though bookings are improving. AI search summaries can impact traditional web article performance. The public market undervaluation of the company's assets drove the decision to pursue asset monetization, which may involve transition costs. The connectivity sale will reduce overall adjusted EBITDA margins.
Generated by AI · Q1 2026 results · Not investment advice
🔒
Free Account Required

Create a free Finmagine account to access Finmagine™ Scorecard.

See how this company scores across 5 dimensions — Financial Health, Growth Prospects, Competitive Position, Management Quality, and Valuation — powered by 30+ computed ratios.

Create Free AccountLog In
🔒
Premium Feature

Upgrade to Finmagine Premium to unlock Ask AI.

Get 25 expert AI analysis templates — Business KPIs, Comprehensive, Forensic Governance, Peer Comparison, Risk-Reward, Full Research Report, IPO Decoder, Red Flag Detector, and more — ready to paste into ChatGPT, Claude, Gemini, or Perplexity.

Upgrade to PremiumCreate Free Account
🔒
Premium Feature

Upgrade to Finmagine Premium to unlock Peer Comparison.

Compare this company side-by-side against its sector peers with financial metrics, ratio benchmarking, and relative performance across all key dimensions.

Upgrade to PremiumCreate Free Account
✓ 📞 Earnings Call Transcripts (5 quarters) submit a missing quarter
🔍
🔎 See cross-company document search → ?
📞 Earnings Call Transcripts (5)
Q2 2026 Q2 2026 2026-08-07
Q2 2026 saw a 2.7% revenue decline and 3.7% drop in adjusted EBITDA, offset by a 13% rise in adjusted EPS due to aggressive share buybacks. The sale of the Connectivity business for $1.2 billion strengthened the balance sheet, enabling further capital returns and strategic flexibility.
Q1 2026 Q1 2026 2026-05-08
Q1 2026 revenue declined 1.9% year-over-year, with adjusted EBITDA and margins also down, but strong off-platform growth and AI-driven innovation are helping offset web traffic headwinds. The company is actively monetizing assets, repurchasing shares, and pursuing targeted acquisitions to unlock value.
Q4 2025 Q4 2025 2026-02-24
Revenue grew 3.5% in 2025 with strong free cash flow and robust share repurchases, despite Tech and Shopping headwinds from declining search traffic. Other segments showed growth, and the company remains focused on profitable growth, M&A, and navigating AI-related uncertainties.
Q3 2025 Q3 2025 2025-11-07
Q3 2025 saw nearly 3% revenue growth, strong free cash flow, and a 7% rise in adjusted EPS, with three of five segments growing. Strategic alternatives are being evaluated to unlock shareholder value, and share buybacks remain a priority.
Q2 2025 Q2 2025 2025-08-07
Q2 2025 saw nearly 10% revenue growth and 12% adjusted EBITDA growth, with four of five segments expanding and robust performance in health, wellness, and connectivity. Guidance for 2025 is reaffirmed, with continued M&A and share repurchases supported by a strong balance sheet.
🔒
Premium Feature

Upgrade to Finmagine Premium to unlock Catalyst Timeline.

Every result, order win, insider trade, ECS update, earnings-call, and SEC announcement for this company — in one chronological lane.

Upgrade to PremiumCreate Free Account
🔒
Premium Feature

Upgrade to Finmagine Premium to unlock Full Report.

Read the complete Finmagine™ investment research report — comprehensive fundamental analysis, business model assessment, competitive positioning, and investment recommendation.

Upgrade to PremiumCreate Free Account

📊 Analysis Methodology

This comprehensive investment analysis was conducted using The Finmagine™ Stock Analysis & Ranking Methodology, a proprietary framework that systematically evaluates stocks across five critical dimensions: Financial Health, Growth Prospects, Competitive Positioning, Management Quality, and Valuation.

🎯
Discover Our Proven Investment Framework Learn how we analyze and rank stocks using advanced quantitative models, multi-dimensional scoring systems, and dynamic discriminatory ranking techniques that have guided successful investment decisions across market cycles.
📊 Explore The Finmagine™ Methodology

A comprehensive, bias-free framework for analyzing and ranking stocks by Financial Strength, Growth Potential, Competitive Edge, Management Quality, and Value.

Financial Model
Projections are built from each company's audited annual financials (Income Statement, Balance Sheet, Cash Flow) over the last 5 fiscal years. Forward assumptions — revenue growth %, EBITDA margin, D&A (USD millions), interest expense, tax rate, and capex — are AI-generated using historical context and refreshed twice a year: after the December results season and after the September/Q4 results season.

DCF Valuation
Fair Value = Σ(FCFt / (1+WACC)t) + Terminal Value. Terminal Value uses the Gordon Growth Model: FCF5 × (1+g) / (WACC−g). Default WACC: 10% (US risk-free ~4.5%, equity risk premium ~5.5%). Default terminal growth: 3% (long-run US nominal GDP proxy).

CAGR Tracker
Expected 5-year CAGR = (DCF Fair Value / Current Price)1/5 − 1. Assumes fair value is reached in exactly 5 years — a mechanical estimate only.

Data Sources & Limitations
Financial statements sourced from public filings. Prices updated daily. Forward assumptions are AI-generated. All monetary values in USD millions. Non-US ADR companies may have currency conversion inaccuracies. Models are point-in-time and do not update intra-quarter or account for M&A, macro shocks, or extraordinary items.

⚠️ Important Disclaimers — Please read without fail.

Investment Risk:
Investing in securities, including US equities and ETFs, involves inherent risks including the potential loss of principal. All investments are subject to market fluctuations, economic conditions, regulatory changes, and other factors that may affect their value. Past performance is not indicative of future results. This analysis is provided for informational and educational purposes only and should not be construed as investment advice under any circumstances.

No Investment Recommendation:
This analysis does not constitute, nor should it be interpreted as, an offer, solicitation, or recommendation to buy, sell, or hold any securities or financial products. Investors are strongly advised to conduct their own independent research and due diligence and to consult with a licensed financial advisor or an SEC-registered investment adviser before making any investment decisions, taking into account their individual financial situation, risk tolerance, and investment objectives.

Not SEC-Registered:
Finmagine is not registered as an investment adviser with the U.S. Securities and Exchange Commission (SEC) or any state securities authority. Nothing on this platform constitutes investment advice as defined under the Investment Advisers Act of 1940.

Conflict of Interest Disclosure:
The author and/or analyst may currently hold or have previously held positions in the securities discussed. Any such positions are not intended to influence the objectivity or independence of the analysis. This research is produced independently and is not sponsored, endorsed, or commissioned by any company or institution.

Information Sources:
The analysis is based on publicly available information including SEC filings (10-K, 10-Q), annual reports, management commentary, and publicly available financial data. Information is believed to be accurate as of the date of publication but may be subject to change without notice. Readers are encouraged to independently verify all information before acting upon it.

Forward-Looking Statements:
This analysis may contain forward-looking statements, forecasts, or projections that are inherently subject to risks, uncertainties, and assumptions. Actual results may differ materially from those expressed or implied. Finmagine does not undertake any obligation to update such statements in the future.

Limitation of Liability:
The content is provided "as is" without any warranties, express or implied. Finmagine expressly disclaims any liability for errors, omissions, or any losses incurred as a result of reliance on the information provided. Readers assume full responsibility for their investment decisions.